PMID: 6965773Mar 1, 1980Paper

The risk of Parkinson disease in Mediterranean people

Neurology
G RosatiM C Devoto

Abstract

On the basis of previous epidemiologic studies, Parkinson disease was thought to be evenly distributed throughout the world. These studies, however, were conducted only on North European populations. The position with regard to the Mediterranean peoples was still unknown, and we therefore studied the frequency of Parkinson disease on the island of Sardinia, where some ethnic groups of the Mediterranean stock are represented. Based on 967 accepted cases, the prevalence 100,000 population on January 1, 1972, was 65.6; the average annual incidence for the period 1961 through 1971 was 4.9. These figures are one-half of the figures established for North Europeans. Our findings suggest racial differences in predisposition to Parkinson disease. Some Negroid features are present in Sardinians. If, as seems likely, Africans prove to be relatively unsusceptible to the disease, the risk for Sardinians and other Mediterranean ethnic groups might be intermediate between North Europeans and Africans.

Citations

Aug 6, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·J M ErreaJ de Pedro-Cuesta
Jan 9, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Dominique TwelvesCarl Counsell
Nov 25, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·A SchragN Quinn
Jan 1, 1981·Journal of Neural Transmission·R J Marttila, U K Rinne
Feb 1, 1989·Trends in Neurosciences·C M Tanner
Jan 1, 1986·Clinical Neurology and Neurosurgery·P P AshokM E Mousa
Sep 23, 1998·Brain Research Bulletin·J M Henderson, S B Dunnett
Aug 25, 2001·Nihon rinsho. Japanese journal of clinical medicine·K Miyoshi
Aug 14, 2003·Parkinsonism & Related Disorders·Jin-Soo Kim, Young H Sohn
Jul 2, 2008·Parkinsonism & Related Disorders·A H Rajput, S Birdi
Mar 7, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D J BausoE Cristiano
Oct 1, 1991·Acta Neurologica Scandinavica·J de Pedro-Cuesta
Nov 1, 1991·Acta Neurologica Scandinavica·J de Pedro-Cuesta, L Stawiarz
Feb 22, 1986·British Medical Journal·W J MutchS K Roy
Oct 6, 2009·Journal of Epidemiology·Weerasak MuangpaisanCarol Brayne
Jun 5, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·A ChiòD Schiffer
Dec 1, 1994·European Journal of Epidemiology·J A DiasZ P Pimenta
Oct 18, 2015·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Luca Degli EspostiStefano Buda
Mar 5, 2008·Parkinsonism & Related Disorders·Gianluca TrifiròVincenzo Arcoraci
Oct 27, 2006·Parkinsonism & Related Disorders·Giovanni CossuVincenzo Bonifati
Sep 17, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Alexei KorchounovNikolay N Yakhno
Jun 4, 2005·Acta Neurologica Scandinavica·R TotaroA Carolei
May 10, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P LindgrenR Dodel
Apr 30, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Hani T S BenamerDonald G Grosset
Jan 1, 1989·Acta Neurologica Scandinavica. Supplementum·R J Marttila, U K Rinne
Jan 1, 1983·Acta Neurologica Scandinavica. Supplementum·R J Marttila
Jun 21, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Sonja von CampenhausenRichard Dodel
Jan 19, 2013·Free Radical Biology & Medicine·Laurie H Sanders, J Timothy Greenamyre
Mar 1, 1990·Archives of Environmental Health·J R GoldsmithZ Weinbaum
Sep 19, 1985·Nature·S H Snyder, R J D'Amato
Sep 24, 2004·Physiological Reviews·Andrzej SlominskiJacobo Wortsman
Jun 9, 2018·The International Journal of Neuroscience·Asmat Ullah KhanRida Zainab
Jul 2, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Graeme EisenhoferVincent J Hearing
Jun 3, 2011·European Journal of Epidemiology·Karin WirdefeldtJack Mandel
Mar 1, 1982·Journal of Neurology, Neurosurgery, and Psychiatry·A NeophytidesR Walker
Oct 1, 1983·Journal of Neurology, Neurosurgery, and Psychiatry·J J MannA Neophytides
Feb 1, 1983·Journal of Neurology, Neurosurgery, and Psychiatry·Y SternJ Ilson
Feb 1, 1991·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·J PoirierS Gauthier
Nov 1, 1986·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·A H RajputW Laverty
Nov 1, 1989·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Y O HerishanuZ Weinbaum
Aug 1, 1987·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·A H RajputA Dua
Jul 1, 1995·Acta Neurologica Scandinavica·F Menniti-IppolitoR Raschetti
Feb 1, 1984·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·R C Duvoisin
Feb 8, 2019·Psychology, Health & Medicine·Paul Kenneth HitchcottMaria Pietronilla Penna

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.